{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "ADPT",
    "data": {
        "bs": [
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 85994000
            },
            {
                "label": "Total liabilities and shareholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 858193000
            },
            {
                "label": "Operating lease liabilities, less current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 104978000
            },
            {
                "label": "Operating lease liabilities, less current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 104978000
            },
            {
                "label": "Deferred revenue, less current portion",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 84894000
            },
            {
                "label": "Accrued compensation and benefits",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 6651000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -4783000
            },
            {
                "label": "Total Adaptive Biotechnologies Corporation shareholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 553205000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 5959000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 118972000
            },
            {
                "label": "Noncontrolling interest",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 50000
            },
            {
                "label": "Current portion of deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 83504000
            },
            {
                "label": "Commitments and contingencies (Note 9)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 85634000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 304938000
            },
            {
                "label": "Preferred stock: $0.0001 par value, 10,000,000 shares authorized at March 31, 2022 and December 31, 2021; no shares issued and outstanding at March 31, 2022 and December 31, 2021",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 22518000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 2382000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 2400000.0
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 10407000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 419120000
            },
            {
                "label": "Long-term marketable securities (amortized cost of $140,202 and $218,163, respectively)",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
                "unit": "usd",
                "value": 137110000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 21002000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 114805000
            },
            {
                "label": "Short-term marketable securities (amortized cost of $250,448 and $214,115, respectively)",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 248757000
            },
            {
                "label": "Current portion of operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 8545000
            },
            {
                "label": "Current portion of operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 8545000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 858193000
            },
            {
                "label": "Common stock: $0.0001 par value, 340,000,000 shares authorized at March 31, 2022 and December 31, 2021; 142,183,258 and 141,393,865 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Total shareholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 553255000
            },
            {
                "label": "Total shareholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 553255000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -781627000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 12038000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 1339601000
            },
            {
                "label": "Intangible assets, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 8107000
            },
            {
                "label": "Intangible assets, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 8107000
            },
            {
                "label": "Intangible assets, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 8107000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 874000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 115066000
            }
        ],
        "cf": [
            {
                "label": "Accounts receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 5109000
            },
            {
                "label": "Net cash provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 37688000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": 20000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -962000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 2749000
            },
            {
                "label": "Investment amortization",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -862000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 4637000
            },
            {
                "label": "Accounts payable and accrued liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -7545000
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 1739000
            },
            {
                "label": "Operating lease right-of-use assets and liabilities",
                "concept": "adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities",
                "unit": "usd",
                "value": 2035000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 2749000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 3077000
            },
            {
                "label": "Intangible assets amortization",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 419000
            },
            {
                "label": "Intangible assets amortization",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 419000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 60235000
            },
            {
                "label": "Proceeds from maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 101000000
            },
            {
                "label": "Noncash lease expense",
                "concept": "adpt:NoncashLeaseExpense",
                "unit": "usd",
                "value": 1792000
            },
            {
                "label": "Purchases of equipment included in accounts payable and accrued liabilities",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 2952000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -64453000
            },
            {
                "label": "Net (decrease) increase in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -24016000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -10812000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 12861000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 37839000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 38620000
            },
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 38620000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -63067000
            },
            {
                "label": "Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 141697252
            },
            {
                "label": "Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 141697252
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 419000
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 419000
            },
            {
                "label": "Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.44
            },
            {
                "label": "Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.44
            },
            {
                "label": "Add: Net loss attributable to noncontrolling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -60000
            },
            {
                "label": "Sales and marketing",
                "concept": "SellingAndMarketingExpense",
                "unit": "usd",
                "value": 26093000
            },
            {
                "label": "Net loss attributable to Adaptive Biotechnologies Corporation",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -62736000
            },
            {
                "label": "Net loss attributable to Adaptive Biotechnologies Corporation",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -62736000
            },
            {
                "label": "Cost of revenue",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 13192000
            },
            {
                "label": "Total operating expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 101687000
            },
            {
                "label": "Interest and other income, net",
                "concept": "InterestAndOtherIncome",
                "unit": "usd",
                "value": 271000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 24144000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -62796000
            },
            {
                "label": "Change in unrealized gains and losses on investments",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -3646000
            },
            {
                "label": "Comprehensive loss attributable to Adaptive Biotechnologies Corporation",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -66382000
            },
            {
                "label": "Add: Comprehensive loss attributable to noncontrolling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -60000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -66442000
            }
        ]
    }
}